ClinicalTrials.Veeva

Menu

The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure

R

Reem Mohammad Alamoudi

Status

Terminated

Conditions

Renal Failure
Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT01937858
RC08/107/A

Details and patient eligibility

About

The value of HbA1c as a tool to determine glycemic control in patients with diabetes and renal failure has not been well studied, the same accepted normal ranges for HbA1c are applied to all patients with diabetes regardless of their renal function. We would like to evaluate the use of HbA1c as a tool of assessing long term glycemic control in this subgroup of patients with diabetes and evaluate the effect of dialysis on HbA1c

Enrollment

50 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients >18 years of age with type 1 or 2 diabetes who show competence in home glucose monitoring and are willing to commit to doing the testing

Exclusion criteria

  • Pregnancy
  • Having received a blood transfusion with in the preceding three months
  • Known to have any hereditary or hemolytic anemia
  • On a medication known to interfere with HbA1c assay (opiates, acetaminophen, vitamin C, vitamin E) - we will allow patients to be on asprin as almost all patients with diabetes are on this drug.
  • Having a blood hemoglobin <7 mg/dl
  • Bilirubin level >20mg/dL or a triglyceride level > 250mg/dL
  • Alcohol addiction

Trial design

50 participants in 3 patient groups

Normal renal function
Stage 2 and 4 and 5 chronic kidney disease
End stage renal disease on hemodialysis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems